Evidence map›Paper›PMID 37947636›Full record

ArticleCells2023

Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells.

Jiahe Lu, Alisa Veler, Boris Simonetti, Timsse Raj, Po Han Chou, Stephen J Cross, Alexander M Phillips, Xiongtao Ruan, Lan Huynh, Andrew W Dowsey and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Proteostasis of immune checkpoint receptors.The Biochemical journal · 2025
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Jiahe LuSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Alisa VelerSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Boris SimonettiSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Timsse RajSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.ORCID 0000-0002-5065-8092
Po Han ChouSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Stephen J CrossWolfson Bioimaging Facility, University of Bristol, Bristol BS8 1TD, UK.ORCID 0000-0003-3565-0479
Alexander M PhillipsDepartment of Electrical Engineering & Electronics and Computational Biology Facility, University of Liverpool, Liverpool L69 7ZX, UK.ORCID 0000-0002-1637-4803
Xiongtao RuanComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0001-5322-3249
Lan HuynhSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Andrew W DowseyBristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK.ORCID 0000-0002-7404-9128
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200032, China.
Robert F MurphyComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0003-0358-901X
Paul VerkadeSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.ORCID 0000-0002-2497-1026
Peter J CullenSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Christoph WülfingSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.ORCID 0000-0002-6156-9861
University of Bristol · GBCarnegie Mellon University · USFudan University Shanghai Cancer Center · CNUniversity of Liverpool · GB

Funding

TrainingP41GM103712 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FAEDER, JAMES · 2012 to 2021
$16.3M
NIGMS NIH HHS P41 GM103712Wellcome Trust
6 · The paper itself

Abstract

T cells can express multiple inhibitory receptors. Upon induction of T cell exhaustion in response to a persistent antigen, prominently in the anti-tumor immune response, many are expressed simultaneously. Key inhibitory receptors are CTLA-4, PD-1, LAG3, TIM3, and TIGIT, as investigated here. These receptors are important as central therapeutic targets in cancer immunotherapy. Inhibitory receptors are not constitutively expressed on the cell surface, but substantial fractions reside in intracellular vesicular structures. It remains unresolved to which extent the subcellular localization of different inhibitory receptors is distinct. Using quantitative imaging of subcellular distributions and plasma membrane insertion as complemented by proximity proteomics and biochemical analysis of the association of the inhibitory receptors with trafficking adaptors, the subcellular distributions of the five inhibitory receptors were discrete. The distribution of CTLA-4 was most distinct, with preferential association with lysosomal-derived vesicles and the sorting nexin 1/2/5/6 transport machinery. With a lack of evidence for the existence of specific vesicle subtypes to explain divergent inhibitory receptor distributions, we suggest that such distributions are driven by divergent trafficking through an overlapping joint set of vesicular structures. This extensive characterization of the subcellular localization of five inhibitory receptors in relation to each other lays the foundation for the molecular investigation of their trafficking and its therapeutic exploitation.

Indexed as

NeoplasmsT-LymphocytesAnimalsCarrier ProteinsCTLA-4 AntigenImmunotherapyMiceCarrier ProteinsCTLA-4 Antigenimaginginhibitory receptorproximity proteomicsT cell activationvesicular trafficking

Identifiers

PMID37947636
PMCPMC10649679
OpenAlexW4388070026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.